New Key Statistics Module, Z-Score and F-Score
NAS:TNGX Key Ratios
| Market Cap $ M | 1,239.66 |
| Enterprise Value $ M | 955.39 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.76 |
| Price/Sales | 27.14 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 42.00 |
| EPS (TTM) $ | -1.12 |
| Beneish M-Score | -2.27 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.77 |
| EV-to-EBITDA | -6.90 |
| PEG | -- |
| Shares Outstanding M | 107.14 |
| Net Margin (%) | -274.04 |
| Operating Margin % | -311.57 |
| Pre-tax Margin (%) | -273.63 |
| Quick Ratio | 7.49 |
| Current Ratio | 7.49 |
| ROA % (ttm) | -29.16 |
| ROE % (ttm) | -46.42 |
| ROIC % (ttm) | -153.95 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.70 |
TNGX Number of Guru Trades
TNGX Volume of Guru Trades
Gurus Latest Trades with NAS:TNGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TNGX is held by these investors
Total 1
Tango Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TNGX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers